Inside our cells, ribosomes—the tireless "protein factories" of life—have just shown off a new skill they haven't used in billions of years. A research team has become the first in the world to ...

Difficult peptide sequences, JR10-mer and Aib-enkephalin, along with a cyclic peptide, MT-II, were successfully synthesized with short synthesis times using Prelude X. Increasing the temperature ...

Image: Marlene Viola Synthetic peptides, generally less than 20 amino acids in length, are essential reagents for a wide range of studies and one of the fundamental tools of proteomics researchers.

A major problem in solid-phase peptide synthesis (SPPS) is aggregation and poor solvation leading to incomplete deprotection and/or coupling steps, resulting in low crude purity peptides. 1 This ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

5-Prime | Nonribosomal Peptide Synthesis What is it? As the name suggests, nonribosomal peptide synthesis (NRPS) generates polypeptides sans ribosome. The resultant peptides, generally short oligomers ...

Solid-Phase Peptide Synthesis (SPPS): A method for synthesising peptides in which the peptide chain is assembled on an insoluble resin, allowing for sequential addition and easy purification.

Peptide Synthesis Market report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price ...

BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai.. The facility expands the company’s peptide ...

Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals. ... Ehab Alramahy, Senior Vice President, Head of Peptide Division, ...

The Neoantigen Peptide Synthesis Service from GenScript can be utilized for various purposes, such as functional testing of potential TCR treatment neoantigen candidates and clinical stage vaccine ...